메뉴 건너뛰기




Volumn 71, Issue 5, 2014, Pages e211-e213

Ipilimumab-associated sweet syndrome in a melanoma patient

Author keywords

[No Author keywords available]

Indexed keywords

IPILIMUMAB; PREDNISONE; MONOCLONAL ANTIBODY;

EID: 84922480856     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.06.042     Document Type: Article
Times cited : (37)

References (5)
  • 1
    • 84896087035 scopus 로고    scopus 로고
    • Ipilimumabassociated Sweet syndrome in a patient with high-risk melanoma
    • Kyllo RL, Parker MK, Rosman I, Musiek AC. Ipilimumabassociated Sweet syndrome in a patient with high-risk melanoma. J Am Acad Dermatol 2014;70:e85-6.
    • (2014) J Am Acad Dermatol , vol.70 , pp. e85-e86
    • Kyllo, R.L.1    Parker, M.K.2    Rosman, I.3    Musiek, A.C.4
  • 2
    • 79953653271 scopus 로고    scopus 로고
    • Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma
    • Kahler KC, Hauschild A. Treatment and side effect management of CTLA-4 antibody therapy in metastatic melanoma. J Dtsch Dermatol Ges 2011;9:277-86.
    • (2011) J Dtsch Dermatol Ges , vol.9 , pp. 277-286
    • Kahler, K.C.1    Hauschild, A.2
  • 3
    • 69949095926 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma
    • Weber J, Thompson JA, Hamid O, Minor D, Amin A, Ron I, et al. A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma. Clin Cancer Res 2009;15:5591-8.
    • (2009) Clin Cancer Res , vol.15 , pp. 5591-5598
    • Weber, J.1    Thompson, J.A.2    Hamid, O.3    Minor, D.4    Amin, A.5    Ron, I.6
  • 4
    • 42949105127 scopus 로고    scopus 로고
    • Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
    • Hodi FS, Butler M, Oble DA, Seiden MV, Haluska FG, Kruse A, et al. Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci U S A 2008;105(8):3005-10.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , Issue.8 , pp. 3005-3010
    • Hodi, F.S.1    Butler, M.2    Oble, D.A.3    Seiden, M.V.4    Haluska, F.G.5    Kruse, A.6
  • 5
    • 0025533170 scopus 로고
    • Acute neutrophilic febrile dermatosis (Sweet syndrome) associated with melanoma
    • Sanchez Conejo-Mir J, Perez Bernal A, Camacho F. [Acute neutrophilic febrile dermatosis (Sweet syndrome) associated with melanoma]. Med Cutan Ibero Lat Am 1990;18:155-8.
    • (1990) Med Cutan Ibero Lat Am , vol.18 , pp. 155-158
    • Sanchez Conejo-Mir, J.1    Perez Bernal, A.2    Camacho, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.